We review our experience with 27 cases of pulmonary and meningeal cryp
tococcosis at the University Hospital, (Kuala Lumpar, Malaysia) where
this is the most common cause of adult meningitis in patients without
debilitating illnesses. Of the 27 cases analysed, six presented primar
ily with pulmonary symptomatology which usually were mainly cough, che
st pain and low grade fever. The rest presented with primarily central
nervous system (CNS) symptomatology of which headaches and fever were
the most consistent symptoms although a third of these patients also
had pulmonary lesions noted on chest radiographs. Treatment in all cas
es was with amphotericin B and 5-fluorocytosine and usually till a tot
al cumulative dose of 1.5 g of amphotericin had been reached (an avera
ge of 10 weeks). Primary pulmonary presentations, if symptomatic, were
treated as per CNS cryptococcosis due to the high likelihood of CNS d
issemination. Incidental pulmonary cryptococcoma found on routine ches
t radiographs were confirmed by biopsy under ultrasound or fluoroscopy
guidance and booked for surgical resection. Death usually occurred ea
rly in patients who presented late. Once patients responded to therapy
, mortality was usually avoided. The only cause of morbidity in surviv
ors was visual impairment or blindness, and this was attributed mainly
to intracranial hypertension with residual deficits determined by the
measures taken to lower intracranial pressures. Our experience sugges
ts that: (i) symptomatic patients should have combination therapy with
5-fluorocytosine and amphotericin B till at least a cumulative dose o
f 1.5 g amphotericin B is reached irrespective of whether they have pr
imary CNS or pulmonary symptomatology; (ii) non-symptomatic pulmonary
cryptococcoma could be treated primarily by surgical resection; (iii)
visual failure or papilloedema should be treated aggressively; and (iv
) prognosis is good with adequate therapy and early presentation.